The Valley Desk

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis SocietyPublished

Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published
Subject terms
Humans; Cystic Fibrosis; Aminophenols; Pyrazoles; Pyridines; Pyrrolidines; Indoles; Quinolones; Cystic Fibrosis Transmembrane Conductance Regulator; Anti-Infective Agents; Mutation; Benzodioxoles
PubMed ID
37100705
PubMed Central ID
PMC10523954
Added to directory
Source checked

Report a correction or request removal